{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:01:38Z","timestamp":1794740498458,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Open Project of Shanghai Key Laboratory of Forensic Science","award":["KF1402"],"award-info":[{"award-number":["KF1402"]}]},{"name":"the Open Project of Key Laboratory of Prevention and treatment of cardiovascular and cerebrovascular diseases, Ministry of Education, China","award":["XN201810"],"award-info":[{"award-number":["XN201810"]}]},{"name":"the Science and Technology Project of Jiangxi Provincial Department of Education","award":["150952"],"award-info":[{"award-number":["150952"]}]},{"name":"the Science and Technology Project of Jiangxi Province","award":["20133BBG70080"],"award-info":[{"award-number":["20133BBG70080"]}]},{"name":"the Key Research and Development Project of Jiangxi Province","award":["20161BBG70082"],"award-info":[{"award-number":["20161BBG70082"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ischemia\/reperfusion (I\/R) injury of heart is one of the major causes of acute cardiac injury, which may result in worsening or even loss of heart function. With novel microRNAs being evolutionarily discovered, numbers of them remained functionally unknown. We aimed to discover novel microRNAs with therapeutic or diagnostic potential in the setting of early cardiac I\/R injury.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Cardiac electrical activity, biochemical detection and histopathology analysis were performed to reveal early changes of cardiac I\/R injury. A microRNA array was performed to screen differential microRNAs in the mouse model of cardiac I\/R injury. The differentially expressed microRNAs were validated in cardiac tissues and in serum samples.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The abnormality in electrocardiogram and increases in serum cTnI levels suggested the successful establishment of cardiac I\/R injury in mice. A total of 1882 microRNAs were identified, of which 11 were significantly down-regulated and 41 were significantly up-regulated at 3\u2009h post reperfusion. microRNA 223-3p and microRNA 3113-5p were among the mostly altered microRNAs and were validated to be up-regulated within the early hours of I\/R injury in heart tissues. In the circulating system, cTnI, a sensitive marker of cardiac injury, or microRNA 223-3p only increased within the first 6\u2009h post I\/R injury. However, microRNA 3113-5p stably increased in the serum, keeping an increase of 2.5-fold throughout the 24\u2009h. In the human serum samples, microRNA 3113-5p was detected to be significantly upregulated as soon as 3\u2009h after I\/R stimuli and kept significantly higher levels within the 48\u2009h.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is the first study that reported the functional roles of microRNA 3113-5p in cardiovascular system. Our data suggested that cardiac microRNA 3113-5p might be a useful target for therapeutic purposes and circulating microRNA 3113-5p might serve as a stable marker for early diagnosis of cardiac I\/R injury.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-019-0894-1","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T15:04:39Z","timestamp":1572534279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["MicroRNA 3113-5p is a novel marker for early cardiac ischemia\/reperfusion injury"],"prefix":"10.1186","volume":"14","author":[{"given":"Yuanyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"894_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.freeradbiomed.2013.06.044","volume":"64","author":"JM Lorenzen","year":"2013","unstructured":"Lorenzen JM, Batkai S, Thum T. Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs. Free Radic Biol Med. 2013;64:78\u201384.","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"894_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.116.309538","volume":"119","author":"MC Woodall","year":"2016","unstructured":"Woodall MC, Woodall BP, Gao E, Yuan A, Koch WJ. Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia\/reperfusion injury. Circ Res. 2016;119(10):1116\u201327.","journal-title":"Circ Res"},{"issue":"1","key":"894_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315\u2013424.","journal-title":"Physiol Rev"},{"issue":"11","key":"894_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJMe1509718","volume":"373","author":"DJ Hausenloy","year":"2015","unstructured":"Hausenloy DJ, Yellon DM. Targeting myocardial reperfusion injury--the search continues. N Engl J Med. 2015;373(11):1073\u20135.","journal-title":"N Engl J Med"},{"key":"894_CR5","first-page":"4565630","volume":"2018","author":"X Wang","year":"2018","unstructured":"Wang X, Wang J, Tu T, Iyan Z, Mungun D, Yang Z, Guo Y. Remote ischemic Postconditioning protects against myocardial ischemia-reperfusion injury by inhibition of the RAGE-HMGB1 pathway. Biomed Res Int. 2018;2018:4565630.","journal-title":"Biomed Res Int"},{"issue":"1","key":"894_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13000-016-0583-2","volume":"11","author":"H Min","year":"2016","unstructured":"Min H, Fan S, Song S, Zhuang Y, Li H, Wu Y, Cai H, Yi L, Dai J, Gao Q. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis. Diagn Pathol. 2016;11(1):135.","journal-title":"Diagn Pathol"},{"issue":"7224","key":"894_CR7","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S. And others. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456(7224):980\u20134.","journal-title":"Nature"},{"issue":"10","key":"894_CR8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.116.023926","volume":"134","author":"H Li","year":"2016","unstructured":"Li H, Zhang X, Wang F, Zhou L, Yin Z, Fan J, Nie X, Wang P, Fu XD, Chen C. And others. MicroRNA-21 lowers blood pressure in spontaneous hypertensive rats by Upregulating mitochondrial translation. Circulation. 2016;134(10):734\u201351.","journal-title":"Circulation"},{"issue":"4","key":"894_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1159\/000489185","volume":"46","author":"X Liu","year":"2018","unstructured":"Liu X, Xu Y, Deng Y, Li H. MicroRNA-223 regulates cardiac fibrosis after myocardial infarction by targeting RASA1. Cell Physiol Biochem. 2018;46(4):1439\u201354.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"894_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000445609","volume":"39","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Y, Du W, Liang H, He H, Zhang L, Pan Z, Li X, Xu C, Zhou Y. And others. MiR-223-3p as a novel MicroRNA regulator of expression of voltage-gated K+ channel Kv4.2 in acute myocardial infarction. Cell Physiol Biochem. 2016;39(1):102\u201314.","journal-title":"Cell Physiol Biochem"},{"key":"894_CR11","first-page":"4","volume":"38","author":"X Zhang","year":"2018","unstructured":"Zhang X, Wang X, Wu J, Peng J, Deng X, Shen Y, Yang C, Yuan J, Zou YZ. The diagnostic values of circulating microRNAs for hypertension and bioinformatic analysis. Biosci Rep. 2018;38:4.","journal-title":"Biosci Rep"},{"issue":"5","key":"894_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/00365513.2018.1480059","volume":"78","author":"Ji-Fang Guo","year":"2018","unstructured":"Guo JF, Zhang Y, Zheng QX, Zhang Y, Zhou HH, Cui LM. Association between elevated plasma microRNA-223 content and severity of coronary heart disease. Scand J Clin Lab Invest. 2018;78(5):1\u20136.","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"issue":"3","key":"894_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/1381612822666151112151924","volume":"22","author":"S Gholamin","year":"2016","unstructured":"Gholamin S, Pasdar A, Khorrami MS, Mirzaei H, Mirzaei HR, Salehi R, Ferns GA, Ghayour-Mobarhan M, Avan A. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. Curr Pharm Des. 2016;22(3):397\u2013403.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"894_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1586\/14737159.2015.1081058","volume":"15","author":"M Ferracin","year":"2015","unstructured":"Ferracin M, Negrini M. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis. Expert Rev Mol Diagn. 2015;15(10):1369\u201381.","journal-title":"Expert Rev Mol Diagn"},{"issue":"7","key":"894_CR15","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3390\/ijms19072075","volume":"19","author":"Jose Islas","year":"2018","unstructured":"Islas JF, Moreno-Cuevas JE. A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update. Int J Mol Sci. 2018;19(7).","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"894_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","volume":"157","author":"TR Cech","year":"2014","unstructured":"Cech TR, Steitz JA. The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 2014;157(1):77\u201394.","journal-title":"Cell"},{"issue":"22","key":"894_CR17","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1161\/01.CIR.100.22.2260","volume":"100","author":"C Csonka","year":"1999","unstructured":"Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, Tosaki A, Schulz R, Ferdinandy P. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation. 1999;100(22):2260\u20136.","journal-title":"Circulation"},{"issue":"2","key":"894_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.vascn.2008.01.001","volume":"57","author":"N Farago","year":"2008","unstructured":"Farago N, Kocsis GF, Feher LZ, Csont T, Hackler LJ, Varga-Orvos Z, Csonka C, Kelemen JZ, Ferdinandy P, Puskas LG. Gene and protein expression changes in response to normoxic perfusion in mouse hearts. J Pharmacol Toxicol Methods. 2008;57(2):145\u201354.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"5","key":"894_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1536\/ihj.17-498","volume":"59","author":"Fan Yang","year":"2018","unstructured":"Yang F, You X, Xu T, Liu Y, Ren Y, Liu S, Wu F, Xu Z, Zou L, Wang G. Screening and function analysis of MicroRNAs involved in exercise preconditioning-attenuating pathological cardiac hypertrophy. Int Heart J. 2018;59(5):1069-76.","journal-title":"International Heart Journal"},{"issue":"4","key":"894_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1556\/ABiol.62.2011.4.7","volume":"62","author":"N Farago","year":"2011","unstructured":"Farago N, Zvara A, Varga Z, Ferdinandy P, Puskas LG. Purification of high-quality micro RNA from the heart tissue. Acta Biol Hung. 2011;62(4):413\u201325.","journal-title":"Acta Biol Hung"},{"issue":"3","key":"894_CR21","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr3667","volume":"16","author":"LL Li","year":"2014","unstructured":"Li LL, Xue AM, Li BX, Shen YW, Li YH, Luo CL, Zhang MC, Jiang JQ, Xu ZD, Xie JH, et al. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Res. 2014;16(3):R56.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"894_CR22","first-page":"83","volume":"3","author":"GC Shukla","year":"2011","unstructured":"Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3(3):83\u201392.","journal-title":"Mol Cell Pharmacol"},{"issue":"2","key":"894_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"1","key":"894_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","volume":"173","author":"DP Bartel","year":"2018","unstructured":"Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20\u201351.","journal-title":"Cell"},{"issue":"3","key":"894_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/cvr\/cvs356","volume":"97","author":"X Wang","year":"2013","unstructured":"Wang X, Ha T, Liu L, Zou J, Zhang X, Kalbfleisch J, Gao X, Williams D, Li C. Increased expression of microRNA-146a decreases myocardial ischaemia\/reperfusion injury. Cardiovasc Res. 2013;97(3):432\u201342.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"894_CR26","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s10620-008-0629-8","volume":"54","author":"CH Yu","year":"2009","unstructured":"Yu CH, Xu CF, Li YM. Association of MicroRNA-223 expression with hepatic ischemia\/reperfusion injury in mice. Dig Dis Sci. 2009;54(11):2362\u20136.","journal-title":"Dig Dis Sci"},{"issue":"38","key":"894_CR27","doi-asserted-by":"publisher","first-page":"20247","DOI":"10.1074\/jbc.M116.732735","volume":"291","author":"D Qin","year":"2016","unstructured":"Qin D, Wang X, Li Y, Yang L, Wang R, Peng J, Essandoh K, Mu X, Peng T, Han Q. And others. MicroRNA-223-5p and -3p cooperatively suppress Necroptosis in ischemic\/Reperfused hearts. J Biol Chem. 2016;291(38):20247\u201359.","journal-title":"J Biol Chem"},{"key":"894_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2148-9-51","volume":"9","author":"JH Thomas","year":"2009","unstructured":"Thomas JH, Emerson RO. Evolution of C2H2-zinc finger genes revisited. BMC Evol Biol. 2009;9:51.","journal-title":"BMC Evol Biol"},{"issue":"4","key":"894_CR29","doi-asserted-by":"publisher","first-page":"e94635","DOI":"10.1371\/journal.pone.0094635","volume":"9","author":"XY Meng","year":"2014","unstructured":"Meng XY, Yu HL, Zhang WC, Wang TH, Mai X, Liu HT, Xu RC. ZFP580, a novel zinc-finger transcription factor, is involved in cardioprotection of intermittent high-altitude hypoxia against myocardial ischemia-reperfusion injury. PLoS One. 2014;9(4):e94635.","journal-title":"PLoS One"},{"issue":"4","key":"894_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.hjc.2018.06.007","volume":"59","author":"Gerasimos Siasos","year":"2018","unstructured":"Siasos G, Tsigkou V, Tousoulis D. Circulating microRNAs as novel biomarkers in heart failure. Hell J Cardiol. 2018;59(4):215-6.","journal-title":"Hellenic Journal of Cardiology"},{"issue":"5","key":"894_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.yjmcc.2011.07.011","volume":"51","author":"C Widera","year":"2011","unstructured":"Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol. 2011;51(5):872\u20135.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-019-0894-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0894-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:13:33Z","timestamp":1604016813000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-019-0894-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s13000-019-0894-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"assertion":[{"value":"7 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal protocol was approved by the Ethical Review Board at the Gannan Medical College (No.: 2016\u2013062) and in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85\u201323, revised 1996). The use of human serum samples for the purposes of basic research was also approved by the Ethical Review Board at the Gannan Medical College (No.: 2019161). Each patient was informed of the purpose of this study and showed full consent to participate into our study. The informed consents were obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study did not involve human participates nor use the tissues from human sources and thus did not need patients\u2019 consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}